Daclatasvir and asunaprevir plus peginterferon alfa and ribavirin in HCV genotype 1 or 4 non-responders.

Jensen, Donald

Daclatasvir and asunaprevir plus peginterferon alfa and ribavirin in HCV genotype 1 or 4 non-responders. [electronic resource] - Journal of hepatology Jul 2015 - 30-7 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1600-0641

10.1016/j.jhep.2015.02.018 doi


Adult
Aged
Antiviral Agents--administration & dosage
Carbamates
DNA, Viral--genetics
Drug Administration Schedule
Drug Carriers
Drug Therapy, Combination
Female
Follow-Up Studies
Genotype
Hepacivirus--genetics
Hepatitis C, Chronic--drug therapy
Humans
Imidazoles--administration & dosage
Interferon-alpha--administration & dosage
Isoquinolines--administration & dosage
Male
Middle Aged
Polyethylene Glycols--administration & dosage
Pyrrolidines
Recombinant Proteins--administration & dosage
Ribavirin--administration & dosage
Sulfonamides--administration & dosage
Treatment Outcome
Valine--analogs & derivatives
Viral Load--genetics
Young Adult